Stocks / AMEX / Perspective Therapeutics Inc.

Perspective Therapeutics Inc.

Our Opinion

Perspective Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing to assess a product’s safety profile.

Company Description

Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Company Website: